SMO ClinPlus CO.,LTD. (SHE:301257)
China flag China · Delayed Price · Currency is CNY
47.82
-0.50 (-1.03%)
May 18, 2026, 4:00 PM EDT

SMO ClinPlus CO.,LTD. Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
860.07842.5803.73760.04586.23502.97
Other Revenue
---00-
860.07842.5803.73760.04586.23502.97
Revenue Growth (YoY)
8.09%4.82%5.75%29.65%16.55%50.01%
Cost of Revenue
639.05624.56607.75528.94426.25371.77
Gross Profit
221.02217.95195.98231.1159.98131.19
Selling, General & Admin
54.8554.2552.3750.2849.8633.74
Research & Development
38.4838.7735.8434.7532.2321.19
Other Operating Expenses
-9.57-9.425.295.182.992.94
Operating Expenses
83.7683.61102.54100.5891.2563.71
Operating Income
137.26134.3493.44130.5268.7367.49
Interest Expense
---0.44-0.32-0.18-0.27
Interest & Investment Income
5.457.2316.3516.446.821.73
Other Non Operating Income (Expenses)
0.84-5.7-0.77-0.480.19-0.52
EBT Excluding Unusual Items
143.56135.86108.58146.1675.5668.42
Gain (Loss) on Sale of Investments
0.040.310.581.140.84-1.47
Gain (Loss) on Sale of Assets
0.020.03-0.120.020.02-0.08
Asset Writedown
-10.9-8.32--0.01-0-0
Other Unusual Items
--12.5413.724.41-
Pretax Income
132.72127.88121.58161.0380.8466.88
Income Tax Expense
18.4918.2415.1526.38.439.11
Net Income
114.23109.64106.43134.7372.4157.77
Net Income to Common
114.23109.64106.43134.7372.4157.77
Net Income Growth
25.36%3.02%-21.00%86.06%25.35%63.58%
Shares Outstanding (Basic)
797979787059
Shares Outstanding (Diluted)
797979797159
Shares Change (YoY)
-1.49%0.78%0.06%11.32%20.98%-
EPS (Basic)
1.451.381.351.721.040.99
EPS (Diluted)
1.451.381.351.711.020.98
EPS Growth
27.25%2.22%-21.05%67.14%3.91%63.09%
Free Cash Flow
30.7627.86-10.29104.632.4837.11
Free Cash Flow Per Share
0.390.35-0.131.330.460.63
Dividend Per Share
--0.2500.1800.083-
Dividend Growth
--38.89%116.61%--
Gross Margin
25.70%25.87%24.38%30.41%27.29%26.08%
Operating Margin
15.96%15.95%11.63%17.17%11.72%13.42%
Profit Margin
13.28%13.01%13.24%17.73%12.35%11.49%
Free Cash Flow Margin
3.58%3.31%-1.28%13.76%5.54%7.38%
EBITDA
144.73141.3998.79135.0872.2970.3
EBITDA Margin
16.83%16.78%12.29%17.77%12.33%13.98%
D&A For EBITDA
7.477.055.354.553.562.81
EBIT
137.26134.3493.44130.5268.7367.49
EBIT Margin
15.96%15.95%11.63%17.17%11.72%13.42%
Effective Tax Rate
13.93%14.26%12.46%16.33%10.42%13.62%
Revenue as Reported
--803.73760.04586.23502.97
Source: S&P Global Market Intelligence. Standard template. Financial Sources.